OXYGENTA PHARMACEUTICAL
Back to Income Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Operating Profit History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹-9.70 Cr | ₹-7.12 Cr | ₹147,599 Cr | ₹3.84 Cr | ₹-7.87 Cr |
What is the latest Operating Profit of OXYGENTA PHARMACEUTICAL ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹-9.70 Cr |
| Mar2024 | ₹-7.12 Cr |
| Mar2023 | ₹147,599 Cr |
| Mar2022 | ₹3.84 Cr |
| Mar2021 | ₹-7.87 Cr |
How is Operating Profit of OXYGENTA PHARMACEUTICAL Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-9.70 Cr | Negative | |
| Mar2024 | ₹-7.12 Cr | Negative | |
| Mar2023 | ₹147,599 Cr | 3,841,628.53 | |
| Mar2022 | ₹3.84 Cr | Positive | |
| Mar2021 | ₹-7.87 Cr | - | |
Compare Operating Profit of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹199.0 Cr | -4% | -10.9% | -33.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -4% |
-10.9% |
-33.3% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses